深部学習を用いた前立腺IMRT患者における線量分布の評価:損失関数がモデル性能に与える影響
Arezoo Kazemzadeh1, Reza Rasti2, Alireza Amouheidari3
1Department of Medical Physics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Physical and engineering sciences in medicine
|February 2, 2026
まとめ
適切な損失関数の選択は、前立腺強度変調放射線治療線量予測のための深部学習モデルを大幅に改善する。モーメント損失のようなドメイン知識の組み込みは、個別化放射線計画の精度を向上させる。
背景:
- 深部学習(DL)モデルは放射線治療線量予測にますます使用されている。
- これらのモデルの最適化には、損失関数の慎重な選択が必要である。
- 前立腺がん強度変調放射線治療(IMRT)計画は、特有の線量測定上の課題を提示する。
研究 の 目的:
- 前立腺IMRT線量予測のためのDLモデル性能に対する異なる損失関数の影響を評価する。
- 標準的な損失関数(MAE、MSE)とドメイン固有の知識を組み込んだ損失関数(DVH損失、モーメント損失)を比較する。
- IMRTにおけるDLベースの線量予測の臨床的適用性を評価する。
主な方法:
- 110例の前立腺がん患者症例の後ろ向き解析。
- 平均絶対誤差(MAE)、二乗平均平方根誤差(MSE)、MAE + 線量体積ヒストグラム(DVH)損失、およびMAE + モーメント損失を用いたDLモデルのトレーニング。
- 標的体積(PTV)およびリスク臓器(OAR)の線量測定指標を用いた性能評価。
- 一元配置分散分析(ANOVA)を用いた統計的比較。
主要な成果:
- MAE + モーメント損失で学習したDLモデルは、OARおよびPTVの線量偏差を減少させる上で優れた性能を示した。
- MAE + モーメント損失、MAE + DVH損失、MSE、およびMAEの平均絶対誤差(MAE)±標準偏差(SD)は、それぞれ(1.76 ± 0.5)Gy、(1.78 ± 0.5)Gy、(1.93 ± 0.6)Gy、および(2.02 ± 0.4)Gyであった。
- すべての予測線量分布は、グラウンドトゥルース計画と比較して臨床的に許容可能な精度を達成した。
結論:
- 損失関数の選択は、DLベースの前立腺IMRT線量予測の最適化にとって重要である。
- 特にモーメント損失のようなドメイン固有の知識を損失関数に統合することは、モデル性能を大幅に向上させる。
- これらの発見は、精密で個別化された放射線療法計画のためのDLモデルの実用的な応用を支持する。
関連する概念動画
Drug Dosing: Geriatric Patients
273
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
273
Drug Dosing: Obese Patients
263
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
263
Loss of Tumor Suppressor Gene Functions
6.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.1K
Cholinesterases: Distribution and Function
1.0K
Cholinesterases are a group of serine hydrolase enzymes that play a crucial role in the breakdown of choline esters. The two primary types of cholinesterases are acetylcholinesterases (AChEs) and butyrylcholinesterase (BuChEs), which differ in their distribution, function, and substrate specificity. AChEs, also known as true cholinesterases, specifically hydrolyze acetylcholine, while BuChEs, often referred to as pseudocholinesterases, can hydrolyze various choline esters, including...
1.0K
Pharmacokinetics in Pediatric Patients: Drug Distribution
304
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
304
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
261
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
261


